Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

INTRODUCTION: Ascertainment of the pattern and temporal change of biomarkers in preclinical (asymptomatic) sporadic Alzheimer's disease (AD) will increase knowledge about early pathogenesis and facilitate interventional therapeutic trials. METHODS: In this prospective longitudinal study, repeat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Autores principales: Stomrud, Erik, Minthon, Lennart, Zetterberg, Henrik, Blennow, Kaj, Hansson, Oskar
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2015
Materias:
CSF Biomarkers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879483/
https://ncbi.nlm.nih.gov/pubmed/27239521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares